DRUG logo
Bright Minds Biosciences Inc.(DRUG)
Last print unknown agoAbout this dataData status
$53.82▲2.52 (4.91%)Stale · unknown old

DRUG Retained Earnings

-$67.11MQuarterly · CAD

Period ending:

DRUG FY Retained EarningsCAD
DRUG FY Retained Earnings2019-09-30: -$78.72K2020-09-30: -$559.09K2021-09-30: -$9.21M2022-09-30: -$24.17M2023-09-30: -$31.55M2024-09-30: -$34.35M2025-09-30: -$46.58M$0.00-$46.58M
2019-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in CAD. Dates are period ends; a fiscal year may differ from a calendar year.

DRUG retained earnings history

Cumulative earnings retained in the business. The available annual fiscal periods series contains 7 observations from Sep 30, 2019 to Sep 30, 2025.

Bright Minds Biosciences Inc Retained Earnings — Annual fiscal periods (CAD)
Period endingRetained Earnings (CAD)
-46,578,317
-34,348,969
-31,547,023
-24,174,798
-9,209,857
-559,094
-78,717

Compare retained earnings

All DRUG financial metrics · DRUG stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.